Zoetis Inc. Revenue
Zoetis Inc. (ZTS) reported Revenue of $2.47 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-06
- Zoetis Inc. revenues for the quarter ending 2026-06-30 was $2.47B, a 0.24% decline year-over-year.
- Zoetis Inc. revenues for the quarter ending 2026-03-31 was $2.26B, a 2.91% increase year-over-year.
- Zoetis Inc. revenues for the quarter ending 2025-12-31 was $2.39B, a 3.02% increase year-over-year.
- Zoetis Inc. revenues for the quarter ending 2025-09-30 was $2.40B, a 0.50% increase year-over-year.
- Zoetis Inc. revenues for fiscal 2025 was $9.47B, a 2.28% increase from fiscal 2024.
- Zoetis Inc. revenues for fiscal 2024 was $9.26B, a 8.33% increase from fiscal 2023.
- Zoetis Inc. revenues for fiscal 2023 was $8.54B, a 5.74% increase from fiscal 2022.
- Zoetis Inc. revenues for fiscal 2022 was $8.08B, a 3.91% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.47B 10-Q · filed 2026-08-06 | $4.73B 10-Q · filed 2026-08-06 | $7.12B derived: sum of 3 quarters · filed 2026-08-06 | $9.52B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $2.26B 10-Q · filed 2026-05-07 | $4.65B derived: sum of 2 quarters · filed 2026-05-07 | $7.05B derived: sum of 3 quarters · filed 2026-05-07 | $9.52B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $2.39B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.79B derived: sum of 2 quarters · filed 2026-02-12 | $7.26B derived: sum of 3 quarters · filed 2026-08-06 | $9.47B 10-K · filed 2026-02-12 | ||
| 2025-09-30 | $2.40B 10-Q · filed 2025-11-04 | $4.87B derived: sum of 2 quarters · filed 2026-08-06 | $7.08B 10-Q · filed 2025-11-04 | $9.39B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $2.47B 10-Q · filed 2026-08-06 | $2.46B 10-Q · filed 2025-08-05 | $4.67B 10-Q · filed 2026-08-06 | $4.68B 10-Q · filed 2025-08-05 | $6.99B derived: sum of 3 quarters · filed 2026-08-06 | $9.38B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.20B 10-Q · filed 2026-05-07 | $2.22B 10-Q · filed 2025-05-06 | $4.51B derived: sum of 2 quarters · filed 2026-05-07 | $6.90B derived: sum of 3 quarters · filed 2026-05-07 | $9.26B derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $2.32B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.71B derived: sum of 2 quarters · filed 2026-02-12 | $7.07B derived: sum of 3 quarters · filed 2026-02-12 | $9.26B 10-K · filed 2026-02-12 | ||
| 2024-09-30 | $2.39B 10-Q · filed 2025-11-04 | $4.75B derived: sum of 2 quarters · filed 2025-11-04 | $6.94B 10-Q · filed 2025-11-04 | $9.15B derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-06-30 | $2.36B 10-Q · filed 2025-08-05 | $4.55B 10-Q · filed 2025-08-05 | $6.76B derived: sum of 3 quarters · filed 2026-02-12 | $8.91B derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-03-31 | $2.19B 10-Q · filed 2025-05-06 | $4.40B derived: sum of 2 quarters · filed 2026-02-12 | $6.55B derived: sum of 3 quarters · filed 2026-02-12 | $8.73B derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2023-12-31 | $2.21B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.36B derived: sum of 2 quarters · filed 2026-02-12 | $6.54B derived: sum of 3 quarters · filed 2026-02-12 | $8.54B 10-K · filed 2026-02-12 | ||
| 2023-09-30 | $2.15B 10-Q · filed 2024-11-04 | $4.33B derived: sum of 2 quarters · filed 2024-11-04 | $6.33B 10-Q · filed 2024-11-04 | $8.37B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-06-30 | $2.18B 10-Q · filed 2024-08-06 | $4.18B 10-Q · filed 2024-08-06 | $6.22B derived: sum of 3 quarters · filed 2025-02-13 | $8.22B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-03-31 | $2.00B 10-Q · filed 2024-05-02 | $4.04B derived: sum of 2 quarters · filed 2025-02-13 | $6.04B derived: sum of 3 quarters · filed 2025-02-13 | $8.09B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2022-12-31 | $2.04B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $4.04B derived: sum of 2 quarters · filed 2025-02-13 | $6.09B derived: sum of 3 quarters · filed 2025-02-13 | $8.08B 10-K · filed 2025-02-13 | ||
| 2022-09-30 | $2.00B 10-Q · filed 2023-11-02 | $4.05B derived: sum of 2 quarters · filed 2023-11-02 | $6.04B 10-Q · filed 2023-11-02 | $8.01B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-06-30 | $2.05B 10-Q · filed 2023-08-08 | $4.04B 10-Q · filed 2023-08-08 | $6.00B derived: sum of 3 quarters · filed 2024-02-13 | $8.00B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-03-31 | $1.99B 10-Q · filed 2023-05-04 | $3.95B derived: sum of 2 quarters · filed 2024-02-13 | $5.94B derived: sum of 3 quarters · filed 2024-02-13 | $7.89B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2021-12-31 | $1.97B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $3.96B derived: sum of 2 quarters · filed 2024-02-13 | $5.91B derived: sum of 3 quarters · filed 2024-02-13 | $7.78B 10-K · filed 2024-02-13 | ||
| 2021-09-30 | $1.99B 10-Q · filed 2022-11-03 | $3.94B derived: sum of 2 quarters · filed 2022-11-03 | $5.81B 10-Q · filed 2022-11-03 | $7.62B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-06-30 | $1.95B 10-Q · filed 2022-08-04 | $3.82B 10-Q · filed 2022-08-04 | $5.63B derived: sum of 3 quarters · filed 2023-02-14 | $7.41B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-03-31 | $1.87B 10-Q · filed 2022-05-05 | $3.68B derived: sum of 2 quarters · filed 2023-02-14 | $5.46B derived: sum of 3 quarters · filed 2023-02-14 | $7.01B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2020-12-31 | $1.81B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $3.59B derived: sum of 2 quarters · filed 2023-02-14 | $5.14B derived: sum of 3 quarters · filed 2023-02-14 | $6.67B 10-K · filed 2023-02-14 | ||
| 2020-09-30 | $1.79B 10-Q · filed 2021-11-04 | $3.33B derived: sum of 2 quarters · filed 2021-11-04 | $4.87B 10-Q · filed 2021-11-04 | $6.54B derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $1.55B 10-Q · filed 2021-08-05 | $3.08B 10-Q · filed 2021-08-05 | $4.76B derived: sum of 3 quarters · filed 2021-08-05 | $6.34B derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $1.53B 10-Q · filed 2021-05-06 | $3.21B derived: sum of 2 quarters · filed 2021-05-06 | $4.79B derived: sum of 3 quarters · filed 2021-05-06 | $6.34B derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $1.67B 10-K · filed 2020-02-13 | $3.26B derived: sum of 2 quarters · filed 2020-11-05 | $4.80B derived: sum of 3 quarters · filed 2020-11-05 | $6.26B 10-K · filed 2022-02-15 | ||
| 2019-09-30 | $1.58B 10-Q · filed 2020-11-05 | $3.13B derived: sum of 2 quarters · filed 2020-11-05 | $4.59B 10-Q · filed 2020-11-05 | $6.15B derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $1.55B 10-Q · filed 2020-08-06 | $3.00B 10-Q · filed 2020-08-06 | $4.57B derived: sum of 3 quarters · filed 2020-08-06 | $6.05B derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $1.46B 10-Q · filed 2020-05-06 | $3.02B derived: sum of 2 quarters · filed 2020-05-06 | $4.50B derived: sum of 3 quarters · filed 2020-05-06 | $5.91B derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2018-12-31 | $1.56B 10-K · filed 2020-02-13 | $3.04B derived: sum of 2 quarters · filed 2020-02-13 | $4.46B derived: sum of 3 quarters · filed 2020-02-13 | $5.83B 10-K · filed 2021-02-16 | ||
| 2018-09-30 | $1.48B 10-K · filed 2020-02-13 | $2.90B derived: sum of 2 quarters · filed 2020-02-13 | $4.26B 10-Q · filed 2019-11-07 | $5.72B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | $1.42B 10-K · filed 2020-02-13 | $2.78B 10-Q · filed 2019-08-06 | $4.24B derived: sum of 3 quarters · filed 2020-02-13 | $5.59B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-03-31 | $1.37B 10-K · filed 2020-02-13 | $2.83B derived: sum of 2 quarters · filed 2020-02-13 | $4.17B derived: sum of 3 quarters · filed 2020-02-13 | $5.44B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2017-12-31 | $1.46B 10-K · filed 2019-02-14 | $2.81B derived: sum of 2 quarters · filed 2019-02-14 | $4.08B derived: sum of 3 quarters · filed 2019-02-14 | $5.31B 10-K · filed 2020-02-13 | ||
| 2017-10-01 | $1.35B 10-K · filed 2019-02-14 | $2.62B derived: sum of 2 quarters · filed 2019-02-14 | $3.85B 10-Q · filed 2018-11-01 | |||
| 2017-07-02 | $1.27B 10-K · filed 2019-02-14 | $2.50B 10-Q · filed 2018-08-02 | ||||
| 2017-04-02 | $1.23B 10-K · filed 2019-02-14 | |||||
| 2016-12-31 | $4.89B 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |